Man Group’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-45,294	Closed	-$242K	–	2169
2024 Q1	$242K	Buy	+45,294	New	+$242K	﹤0.01%	1840
2022 Q3	–	Hold	0	–	-$10K	–	2214
2022 Q2	–	Hold	0	–	–	–	1965